How Options Technology is Shaping Global Careers in Fintech from Belfast

As the global capital markets industry becomes increasingly dependent on advanced technology, Belfast-based Options Technology continues to set the standard. Supporting over 550 clients worldwide, the company delivers high-performance trading infrastructure and cloud services to many of the world’s leading financial institutions.

But it's not just about technology; Options is equally committed to developing people, fostering community, and making a meaningful impact both locally and globally.

Founded in 1993 as a niche service provider to hedge funds, Options has evolved into a global fintech powerhouse, operating across major financial centres including London, New York, Tokyo, and Paris, with recent expansions into Sydney, Dubai, Hong Kong, Toronto, Chicago, and Auckland.

Central to Options’ growth is its investment in people. The 2025 Graduate and Placement Programme offers hands-on experience in cyber security, cloud computing, artificial intelligence, and software development. More than 50% of annual hires join through this route, and a quarter of last year’s recruits were placement students. Remarkably, 60% of Options’ global management team began as graduate hires, showcasing the company’s commitment to nurturing talent.

Leadership development is also a key focus, with the Options Elevate programme, a six-month executive coaching initiative, equipping employees with the tools to lead effectively.

In Belfast, Options’ headquarters features a dedicated AI and machine learning hub, 24/7 gym, wellness facilities, and modern collaboration zones, designed to support innovation, health, and connection. The company also plays a proactive role in the local tech scene, hosting the Capital Markets Meet-up, a key networking event in Belfast.

Options leads by example in social impact, with employees participating in challenges like the Mourne Seven Sevens Challenge and the London Marathon, raising significant funds for charities such as the Royal National Institute of Blind People and Macmillan Cancer Support.